Lin Li

Lin Li is a Postdoctoral Researcher at the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Sweden. Her work focuses on psychiatric and pharmacoepidemiology, with a primary affiliation to the research group of Zheng Chang.

• Education: PhD in Medical Sciences from Örebro University (2022).
• Grants: Funded by Fonden för Psykisk Hälsa, KI Research Foundation, Stiftelsen Sven Jerrings Fond, The Swedish Heart Lung Foundation, The Söderström König Foundation, Fredrik och Ingrid Thurings Stiftelse.

Research Interests: Lin Li specializes in leveraging large-scale national health registers, twin studies (Swedish Twin Register), and systematic reviews/meta-analyses to investigate ADHD's links to cardiovascular diseases (CVD), cardiometabolic risk profiles, and type 2 diabetes. Her work evaluates psychotropic medication safety via advanced pharmacoepidemiological methods and explores gene-environment interactions in ADHD symptom dimensions.

Publications: She has contributed to high-impact journals including JAMA Psychiatry, The Lancet Psychiatry, and BMC Medicine. Key article trends include ADHD pharmacotherapy risks, twin studies on genetic/environmental mechanisms, and population-based cohort analyses of cardiometabolic comorbidities.

Collaborations: Li works with international teams across Sweden, Norway, and multidisciplinary institutions like the Norwegian Mother, Father and Child Cohort Study (MoBa). Her research spans clinical, genetic, and social epidemiology domains.